作者: Ali G. Gharavi , Yan Yan , Francesco Scolari , F. Paolo Schena , Giovanni M. Frasca
DOI: 10.1038/81677
关键词:
摘要: End-stage renal disease (ESRD) is a major public health problem, affecting 1 in 1,000 individuals and with an annual death rate of 20% despite dialysis treatment 1, 2. IgA nephropathy (IgAN) is the most common form of glomerulonephritis, a principal cause of ESRD worldwide 1, 2; it affects up to 1.3% of the population 3, 4, 5, 6 and its pathogenesis is unknown. Kidneys of people with IgAN show deposits of IgA-containing immune complexes with proliferation of the glomerular mesangium (Fig. 1). Typical clinical features include …